Specialty

Oncology Revenue Cycle Automation

Oncology revenue cycle management involves prior authorization for chemotherapy regimens and imaging, complex drug coding and billing, clinical trial billing considerations, and time-sensitive treatment schedules where authorization delays directly impact patient care. Sarva automates oncology-specific PA submissions, manages drug coding validation, and prioritizes authorizations by treatment urgency.

Specialty-Specific RCM Challenges

Treatment-Critical PA Timing

Chemotherapy and radiation therapy authorizations are time-sensitive. Delays directly impact patient treatment schedules.

Drug Coding Complexity

Oncology drugs have complex coding including J-ccodes, administration codes, and wastage documentation. Errors cause significant revenue loss.

Clinical Trial Billing

Services related to clinical trials require careful billing distinction between standard of care and research-related services.

Imaging Authorization

Oncology relies heavily on PET/CT and MRI for treatment monitoring, all requiring PA through radiology benefit managers.

Authorization Issues

Oncology prior authorizations are treatment-critical. Sarva prioritizes oncology PAs with 24-hour escalation thresholds (vs. 48 hours for other specialties), auto-generates submissions with clinical documentation supporting the treatment regimen, and tracks status with real-time alerts to prevent treatment delays.

Common Denial Categories

CO-197
Authorization Required
Denial when chemotherapy or imaging is administered without prior authorization.
CO-11
Drug Coding Error
Denial when J-code or administration coding is incorrect or wastage is not properly documented.
CO-50
Medical Necessity
Denial when the payer disputes the medical necessity of a treatment regimen.

Workflow Example

A patient is prescribed a chemotherapy regimen. Sarva identifies all components requiring PA, auto-generates submissions for each, and tracks approval with 24-hour escalation. Drug coding is validated against the regimen — J-codes, administration codes, and wastage documentation are checked before claim submission.

KPI Focus

PA turnaround time for oncologyDrug coding accuracyTreatment delay rate from PAChemotherapy claim denial rateClinical trial billing compliance

See how Sarva handles your specialty's RCM challenges.

Book an RCM Automation Demo

Frequently Asked Questions

Sarva applies 24-hour escalation thresholds for oncology PAs (vs. 48 hours for other specialties), recognizing that treatment delays directly impact patient care. Real-time alerts notify staff when oncology PAs are pending beyond 24 hours.

Ready to automate oncology revenue cycle?

Book a personalized demo with a specialist who understands your specialty.